Pfizer just released its first safety data about COVID-19 vaccines for children ages 5 to 11, reassuring parents that a safe and effective vaccine soon could be available for those younger than 12.
for children ages 5 to 11, reassuring parents that a safe and effective vaccine soon could be available for those younger than 12.
Other experts have stressed that size isn't everything. Because the lower dose still mounts a strong and sufficient antibody response to COVID-19, even an 11-year-old who's taller or weighs more than a kid over 12 should be protected. At this point in the pandemic, more than 5 million American children -- most not eligible for vaccination -- have tested positive for COVID-19. Children make up 22.2% of the U.S. population but accounted for almost 30% of new COVID-19 cases in a single week, based on early September data compiled by the American Academy of Pediatrics.
In fact, researchers discovered that when 5-to-11-year-old children in the trial received the 30-microgram dose, they had more side effects. With the lower dosage, side effects mirrored those seen in teens and adults -- pain at the injection site, headaches and fatigue.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: NI records four Covid-linked deaths, 1,060 casesThe total number of deaths linked to coronavirus in NI since the start of the pandemic is 2,517.
Read more »
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on ThursdayThe CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration. Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older.
Read more »
Pfizer Study of Covid-19 Vaccine in Pregnant Women Delayed by Slow EnrollmentPfizer wanted to study its Covid-19 vaccine in pregnant women, but then the shots became widely available; “It’s hard to enthusiastically recommend the study when you’ve got a vaccine out there,” says one doctor
Read more »
U.S. administers 386.2 mln doses of COVID-19 vaccines - CDCThe United States has administered 386,237,881 doses of COVID-19 vaccines in the country as of Monday morning, the U.S. Centers for Disease Control and Prevention said.
Read more »